Check more videos: 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16 - 17 - 18 - 19
![]()
Pfizer sees good value in deal with Biocon: Pharmasianews
Views: | Time:
Vikas Dandekar, pharmasianews.com, Biocon, Pfizer, diabetes, Sanofi-Aventis | ![]()
Ranbaxy to have 30% mkt share for Lipitor: PharmAsiaNews
Views: | Time:
US FDA, Ranbaxy, pharmasianews.com, Lipitor, | ![]()
Ranbaxy might monetise FTFs through deals: Pharmasianews
Views: | Time:
Vikas Dandekar, pharmasianews.com, Ranbaxy, |
![]()
Ranbaxy may monetise first-to-file via deals: Pharmasianews
Views: | Time:
Vikas Dandekar, pharmasianews.com, Ranbaxy, | ![]()
Dr Reddy's speaking to potential partners for bio-similars
Views: | Time:
Dr Reddys, bio-similars, Vikas Dandekar, pharmasianews.com, | ![]()
Biocon files IND for IN-105 oral insulin with USFDA
Views: | Time:
Vikas Dandekar, pharmasia News.com, |
![]()
Pharma outlook: What's brewing at DRL, Lupin, Pfizer?
Views: | Time:
Vikas Dandekar, pharmasianews.Com, pharmaceutical, Fonda Pariniux, Dr Reddy's, Lupin | ![]()
Pharma buzz: Sector outlook, cos to look at
Views: | Time:
Vikas Dandekar, Templeton, pharmasianews.com, Sun Pharma, Taro, Levitt family | ![]()
Pharma M&A: Should govt fret over foreign takeovers?
Views: | Time:
Ranbaxy Vikas Dandekar, Pharmasianews.com, |
![]()
AstraZeneca takes Lupin to NJ court over Nexium
Views: | Time:
astrazeneca, Lupin, New Jersey Court, Nexium, anti-ulcer blockbuster, Vikar Dandekar | ![]()
Hospira to acquire Orchid's injectibles biz for $400m
Views: | Time:
Orchid Chemicals, Hospira, Vikas Dandekar, pharmasianews.com, | ![]()
CNBC WHAT'S HOT: FORTIS - WOCKHARDT DONE DEAL
Views: | Time:
Wockhardt, Fortis, hospitals, beds, debt, win-win deal |
![]()
Hospira to acquire Orchid's injectibles biz for $400m
Views: | Time:
Orchid Chemicals, Hospira, Vikas Dandekar, pharmasianews.com, | ![]()
Ranbaxy to find a new CFO
Views: | Time:
pharmasia News, Reema Tendulkar, Omesh Sethi, | ![]()
Ranbaxy Merck call off anti-infectives deal
Views: | Time:
Vikas Dandekar, pharmasia News, Ranbaxy, Merck, anti-infectives, |